Banner "For Industry - for Development in Japan"
Overview
Message for Overseas Company
[Drugs]
[Regenerative Medical Products]
[Medical Devices]
[Others]
- Supports from Japanese government (MHLW)(PDF)[1.4MB] (external link)
[ENDPOINTS Events]
Note: Registration (free of charge) is required to view the videos.
- Why Japan for drug development
- Navigating regulatory pathways for rare disease drugs in Japan [1.06MB]
ENDPOINTS Events on-Demand Session (November 19th, 2025) (external link)
About PMDA
Regulations and Services of PMDA
Information for Approved Products in Japan
Procedures in Japan
Advanced Efforts
Links
Public Organizations and Services
- Ministry of Health, Labour and Welfare (MHLW)
- Japan Agency for Medical Research and Development (AMED)
- National Institutes of Biomedical Innovation, Health and Nutrition(NIBN)
- Ministry of Economy, Trade and Industry (METI)
- Japan External Trade Organization (JETRO)
- Cabinet Secretariat : Council of the Concept for Early Prevalence of the Novel Drugs to Patients by Improving Drug Discovery Capabilities
Industry Associations
- Japan Pharmaceutical Manufacturers Association (JPMA)
- Pharmaceutical Research and Manufacturers of America (PhRMA)
- European Federation of Pharmaceutical Industries and Associations, Japan (EFPIA Japan)
- The Japan Federation of Medical Devices Associations (JFMDA)
- American Medical Devices and Diagnostics Manufacturers' Association (AMDD)
- EUROPEAN BUSINESS COUNCIL IN JAPAN (EBC)
- Advanced Medical Technology Association (AdvaMed)
- Forum for Innovative Regenerative Medicine (FIRM)
- Japan CRO Association (JCROA)